{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","record_version":"public-1:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-24T04:46:20.339259+00:00","published_at":"2026-10-24T04:46:20.339259+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:bspeos1ne1524","event_type":"CEO_CHANGED","effective_at":"2026-04-30","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:chandler-d-robinson","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5756921eb9832fa7296bf1bd1883cb513e9fe5a4af39dab2734db553a501c421"],"summary":"Chandler D. Robinson executive of Monopar Therapeutics, effective 2026-04-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:14dp2a61idx4t6","event_type":"DIRECTOR_APPOINTED","effective_at":"2025-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:lavina-talukdar-cfa","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Lavina Talukdar, CFA seat on Monopar Therapeutics, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:x3krn8anqv4m","event_type":"COMMITTEE_CREATED","effective_at":"2025-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:committee:monopar-therapeutics:audit-compensation-nominating-and-governance","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Audit; Compensation; Nominating and Governance committee of Monopar Therapeutics, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1rb8t6u1blzf3u","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2025-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:lavina-talukdar-cfa","alpha:committee:monopar-therapeutics:audit-compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Lavina Talukdar, CFA member of Audit; Compensation; Nominating and Governance, effective 2025-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ii7eav1jgc5bd","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:kim-r-tsuchimoto","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Kim R. Tsuchimoto seat on Monopar Therapeutics, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:v2w7ml59y6wz","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:arthur-j-klausner-mba","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Arthur J. Klausner, MBA seat on Monopar Therapeutics, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1bj7l0thi6um7","event_type":"DIRECTOR_APPOINTED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:raymond-w-anderson-mba-ms","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Raymond W. Anderson, MBA MS seat on Monopar Therapeutics, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:geha851o51pyf","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:committee:monopar-therapeutics:audit-chair-compensation-chair-nominating-and-governance","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Audit · Chair; Compensation · Chair; Nominating and Governance committee of Monopar Therapeutics, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:mhx3qx1e322yv","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:raymond-w-anderson-mba-ms","alpha:committee:monopar-therapeutics:audit-chair-compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Raymond W. Anderson, MBA MS member of Audit · Chair; Compensation · Chair; Nominating and Governance, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1f8z9cnkoak9b","event_type":"COMMITTEE_CREATED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:committee:monopar-therapeutics:audit-compensation-nominating-and-governance-chair","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of Monopar Therapeutics, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fkq7o314arfxn","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2017-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:arthur-j-klausner-mba","alpha:committee:monopar-therapeutics:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Arthur J. Klausner, MBA member of Audit; Compensation; Nominating and Governance · Chair, effective 2017-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:sqb6db1jypw5b","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:chandler-d-robinson-md-mba-msc","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Chandler D. Robinson, MD MBA MSc seat on Monopar Therapeutics, effective 2014-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:nna3qk4ssgt6","event_type":"DIRECTOR_APPOINTED","effective_at":"2014-01-01","detected_at":"2026-10-24T04:46:20.339259+00:00","subject_ids":["alpha:person:christopher-m-starr-phd","alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2"],"caused_claim_ids":["alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595"],"summary":"Christopher M. Starr, PhD seat on Monopar Therapeutics, effective 2014-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:arthur-j-klausner-mba","object_label":"Arthur J. Klausner, MBA","object_source_name_forms":[],"value":"Arthur J. Klausner, MBA: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:6","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:chandler-d-robinson-md-mba-msc","object_label":"Chandler D. Robinson, MD MBA MSc","object_source_name_forms":[],"value":"Chandler D. Robinson, MD MBA MSc: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:chandler-d-robinson-md-mba-msc","name":"Chandler D. Robinson, MD MBA MSc"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:7","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christopher-m-starr-phd","object_label":"Christopher M. Starr, PhD","object_source_name_forms":[],"value":"Christopher M. Starr, PhD: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christopher-m-starr-phd","name":"Christopher M. Starr, PhD"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2014-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2014-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2014-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:8","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:kim-r-tsuchimoto","object_label":"Kim R. Tsuchimoto","object_source_name_forms":[],"value":"Kim R. Tsuchimoto: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:kim-r-tsuchimoto","name":"Kim R. Tsuchimoto"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lavina-talukdar-cfa","object_label":"Lavina Talukdar, CFA","object_source_name_forms":[],"value":"Lavina Talukdar, CFA: Director, Audit; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:raymond-w-anderson-mba-ms","object_label":"Raymond W. Anderson, MBA MS","object_source_name_forms":[],"value":"Raymond W. Anderson, MBA MS: Director, Audit · Chair; Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2017-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2017-01-01","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-04-30","effective_from":"2017-01-01","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:11","subject_id":"alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:chandler-d-robinson","object_label":"Chandler D. Robinson","object_source_name_forms":[],"value":"Chandler D. Robinson: CEO, Co-Founder and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:chandler-d-robinson","name":"Chandler D. Robinson"},"title":"CEO, Co-Founder and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-04-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-04-30","valid_to":null,"recorded_at":"2026-10-24T04:46:20.339259+00:00","sources":[{"id":"alpha:projection-evidence:document:5756921eb9832fa7296bf1bd1883cb513e9fe5a4af39dab2734db553a501c421","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MNPR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774926014183/mnpr20260330_def14a.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T05:28:56.171747+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-04-30T00:00:00+00:00","effective_from":"2026-04-30","effective_until":null,"observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:e0d4bf8a2f131b4a3cabcabfb9a72c09f338cbe74f42b88603b1c461dce2b595","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"Monopar Therapeutics DEF 14A 2025-04-30","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm","source_date":"2025-04-30","retrieved_at":"2026-04-28T23:29:00.777+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5756921eb9832fa7296bf1bd1883cb513e9fe5a4af39dab2734db553a501c421","identity_scope":"source_document_reference","source_type":"sec_filing","title":"MNPR DEF 14A executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1645469/000143774926014183/mnpr20260330_def14a.htm","source_date":"2026-04-30T00:00:00+00:00","retrieved_at":"2026-05-16T05:28:56.171747+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.83,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.887,"cross_source_agreement":0.75,"temporal_completeness":0.438},"diagnostics":{"published_claims":23,"factual_claims":23,"claims_with_linked_evidence":23,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":16,"temporal_claims_with_valid_from":7,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-24T04:46:20.339259+00:00","observed_at":"2026-10-24T04:46:20.339259+00:00","reviewed_at":"2026-10-24T04:46:20.339259+00:00","verified_at":"2026-10-24T04:46:20.339259+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":23,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/monopar-therapeutics/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}